Extraosseous primary and recurrent giant cell tumors: Transforming growth factor-β1 and -β2 expression may explain metaplastic bone formation

Human Pathology

Volumn 27, Issue 7, 1996, Pages 625-632

  Teot, Lisa A ^b   O'Keefe, Regis J ^b   Rosier, Randy N ^b   O'Connell, John X ^b   Fox, Edward J ^b   Hicks, David G ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b NONE

Author keywords

giant cell tumor; immunohistochemistry; in situ hybridization; osseous metaplasia; transforming growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ADULT; ARTICLE; CANCER RECURRENCE; CARCINOGENESIS; CASE REPORT; CELL DIFFERENTIATION; COMBINED IMMUNODEFICIENCY; FEMALE; GIANT CELL TUMOR; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METAPLASIA; OSSIFICATION; OSTEOBLAST; RNA SYNTHESIS;

EID: 0029984166     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90389-5     Document Type: Article

References (32)

1. Carrasco CH, Murray JA: Giant cell tumors. Orthop Clin North Am 20:395-405, 1989
2. Campanacci M, Baldini N, Boriani S, et al: Giant-cell tumor of bone. J Bone Joint Surg 69A:106-114, 1987
3. Maloney JW, Vaughan LM, Jones M, et al: Benign metastasizing giant cell tumor of bone. Clin Orthop 243:208-215, 1989
4. Cooper KL, Beabout JW, Dahlin DC: Giant cell tumor: Ossification in soft-tissue implants. Radiology 153:597-602, 1984
5. Salm R, Sissons HA: Giant-cell tumours of soft tissues. J Pathol 107:27-39, 1972
6. Mirra JM: Giant cell tumors, in Mirra JM, Picci P, Gold RH (eds): Bone Tumors: Clinical, Radiologie and Pathologic Considerations, vol 2, Malvern, PA, Lea & Febiger, 1989, pp 989-999
7. Crabb ID, Hughes SS, Hicks DG, et al: Non-radioactive in situ hybridization using digoxigenin labeled oligonucleotides: Applications to musculoskeletal tissues. Am J Pathol 141:579-589, 1992
8. James IE, Dodds RA, Olivera DL, et al: The ability of human osteoclastoma-derived stromal cells to form bone in vivo is correlated with their ability to mineralize in vitro. J Bone Min Res 10:S235, 1995 (suppl, abstr)
9. Centrella M, McCarthy TL, Canalis E: Transforming growth factor-beta and remodeling of bone. J Bone Joint Surg 73A:1418-1428, 1991
10. Canalis E, McCarthy TL, Centrella M: The role of growth factors in skeletal remodeling. Endocrinol Metab Clin North Am 18:903-918, 1989
11. Yang L, Yan J: Immunohistochemical observations on bone morphogenetic protein in normal and abnormal conditions. Clin Orthop 257:249-256, 1990
12. Wozney JM, Rosen V: Bone morphogenetic proteins, in Mundy GR, Martin TJ (eds): Physiology and Pharmacology of Bone. New York, NY, Springer-Verlag, 1993, pp 725-748
13. Centrella M, Massague J, Canalis E: Human platelet-derived transforming growth factor-beta stimulates parameter of bone growth in fetal rat calvariae. Endocrinology 119:2306-2312, 1986
14. Centrella M, McCarthy TL, Canalis E: Transforming growth factor-beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem 262:2869-2874, 1987
15. Noda M, Rodan GA: Type-beta transforming growth factor (TGF-Beta) regulation of alkaline phosphatase expression and other phenotype-related messenger RNAs in osteoblastic rat osteosarcoma cells. J Cell Physiol 133:426-437, 1987
16. Trippel SB: Biologic regulation of bone growth, in Brighton CT, Friedlanender GE, Lane JM (eds): Bone Formation and Repair. Rosemont, IL, American Academy of Orthopaedic Surgeons, 1994, pp 39-60
17. Joyce ME, Jingushi S, Bolander ME: Transforming growth factor in the regulation of fracture repair. Orthop Clin North Am 21:199-209, 1990
18. Sawyer JR, Myers MA, Rosier RN, et al: Heterotopic ossification: Clinical and cellular aspects. Calcif Tissue Int 49:208-215, 1991
19. Hahn GV, Kaplan FS: Heterotopic ossification, in Brighton CT, Friedlanender GE, Lane JM (eds): Bone Formation and Repair. Rosemont, IL, American Academy of Orthopaedic Surgeons, 1994, pp 79-92
20. Jaffe HL, Lichtenstein L, Portis RB: Giant cell tumor of bone. Arch Pathol Lab Med 30:993-1031, 1940
21. Goldring SR, Schiller AL, Mankin HJ, et al: Characterization of cells from human giant cell tumors of bone. Clin Orthop 204:59-75, 1986
22. Aparisi T, Arborgh B, Ericsson JLE: Giant cell tumor of bone. Virchows Arch A Pathol Anat 376:273-298, 1977
23. Komiya S, Sasguri Y, Inoue A, et al: Characterization of cells cultured from human giant-cell tumors of bone: Phenotypic relationship to the monocyte-macrophage and osteoclast. Clin Orthop 258:304-309, 1990
24. Goldring SR, Dayer JM, Russell RGG, et al: Response to hormones of cells cultured from human giant cell tumor of bone. J Clin Endocrinol Metab 46:425-433, 1978
25. Burmester GR, Winchester RJ, Dimitriu-Bona A, et al: Delineation of four cell types comprising the giant cell tumor of bone. J Clin Invest 71:1633-1648, 1983
26. Athanasou NA, Bliss E, Gatter KC, et al: An immunohistological study of giant-cell tumour of bone: Evidence for an osteoclast origin of the giant cells. J Pathol 147:153-158, 1985
27. Huvos AG: Giant-cell tumor of bone, in Huvos AG (ed): Bone Tumors: Diagnosis, Treatment, and Prognosis, Philadelphia, PA, Saunders, 1991, pp 429-469
28. Chalmer J, Gray DH, Rush J: Observations on the induction of bone in soft tissues. J Bone Joint Surg 57B:36-45, 1975
29. Harris WH, Heaney RP: Skeletal renewal and metabolic bone disease. N Engl J Med 280:253-259, 1969
30. Harris WH, Heaney RP: Skeletal renewal and metabolic bone disease. N EnglJ Med 280:303-311, 1969
31. Puzas JE, Ishibe M, Parker JF, et al: A hypothesis to explain the spatial coupling of bone formation to bone resorption. Transactions of the 39th Annual Meeting of the Orthopaedic Research Society 18:18A, 1993 (abstr)
32. Parfitt AM: The cellular basis of bone remodeling: The quantum concept reexamined in light of recent advances in the cell biology of bone. Calcif Tissue Int 36:S37-S45, 1984 (suppl)